Rabenta 20 

Presentation: Each tablet of Rabenta 20 contains Rabeprazole Sodium INN equivalent to Rabeprazole 20 mg. 

Indications: Rabenta (Rabeprazole) is a proton pump inhibitor (PPI) indicated for the treatment of conditions associated with excessive stomach acid production, including:

• Duodenal ulcers
• Gastric ulcers
• Gastroesophageal reflux disease (GERD)
• Erosive esophagitis (acid-related damage to the lining of the esophagus)
• Treatment of Helicobacter pylori infection (in combination with antibiotics)
• Zollinger-Ellison syndrome

Dosage and Administration: Rabenta 20 tablets should be swallowed whole with liquid and should not be chewed or crushed. It is recommended to take Rabenta once daily, preferably in the morning before food. The duration of treatment depends on the condition being treated.

• Duodenal ulcers: The usual adult dose is 20 mg once daily for 2-4 weeks.
• Gastric ulcers: The usual adult dose is 20 mg once daily for 4-8 weeks.
• GERD: The usual adult dose is 20 mg once daily for 4-8 weeks. For maintenance therapy, a dose of 10 mg or 20 mg once daily may be used.
• Erosive esophagitis: The usual adult dose is 20 mg once daily for 4-8 weeks. For maintenance therapy, a dose of 10 mg or 20 mg once daily may be used.
• H. pylori eradication: Rabeprazole 20 mg is usually given twice daily in combination with specific antibiotics for 7 days.
• Zollinger-Ellison syndrome: The starting dose is usually 60 mg once daily, which may be adjusted by the physician based on individual needs, up to 120 mg daily. Doses above 100 mg may be given in two divided doses.

The dosage and duration of treatment should be determined by a physician based on the individual patient's condition and response to therapy.

Side Effects: Common side effects of Rabenta (Rabeprazole) may include:

• Headache
• Diarrhoea
• Nausea
• Vomiting
• Abdominal pain
• Flatulence
• Constipation
• Sore throat
• Runny nose
• Weakness

Less common side effects may include dizziness, dry mouth, insomnia, and skin rash. Long-term use may be associated with a slightly increased risk of bone fractures, low magnesium levels, and vitamin B12 deficiency.

Precautions: Rabenta (Rabeprazole) is contraindicated in patients with known hypersensitivity to rabeprazole or any other proton pump inhibitors. Caution should be exercised in patients with:

• Severe liver impairment.
• A history of allergic reactions to other PPIs.
• Risk factors for osteoporosis (long-term use may increase the risk of fractures).

Inform your doctor about all other medications you are taking, including over-the-counter drugs and herbal supplements, asrabeprazole can interact with certain medicines, such as ketoconazole, itraconazole, and warfarin.

Use in Pregnancy and Lactation: Rabenta is generally not recommended during pregnancy unless clearly needed and the potential benefits outweigh the risks to the foetus. It is not known whether rabeprazole is excreted in human milk. Caution should be exercised when administering Rabenta to breastfeeding women, and it is best to consult a healthcare professional.

Storage: Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.